Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

19981,389 citationsJournal Article

Authors

Paul M. Ridker · The University of Texas Health Science Center at Houston

Nader Rifai · United States Department of Veterans Affairs

Marc A. Pfeffer · The University of Texas Health Science Center at Houston

Frank M. Sacks · The University of Texas Health Science Center at Houston

Lemuel A. Moyé · United States Department of Veterans Affairs

Steven Goldman · United States Department of Veterans Affairs

Abstract

Evidence of inflammation after MI is associated with increased risk of recurrent coronary events. Therapy with pravastatin may decrease this risk, an observation consistent with a nonlipid effect of this agent.

Topics & Keywords

Lipoproteins and Cardiovascular Health Adipokines, Inflammation, and Metabolic Diseases Acute Myocardial Infarction Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 98, Issue 9, pp. 839-844

DOI: 10.1161/01.cir.98.9.839

Field-Weighted Citation Impact: 81.71